Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, JD Health International's Enterprise Value is HK$39,596 Mil.
JD Health International's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2,956 Mil. Therefore, JD Health International's EV-to-EBIT ratio for today is 13.39.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of JD Health International's Enterprise Value
For the Medical Care Facilities subindustry, JD Health International's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International's Enterprise Value Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Enterprise Value distribution charts can be found below:
* The bar in red indicates where JD Health International's Enterprise Value falls into.
JD Health International Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
JD Health International's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International (HKSE:06618) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
JD Health International's current Enterprise Value is HK$39,596 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. JD Health International's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2,956 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
JD Health International's EV-to-EBITDA for today is:
JD Health International's current Enterprise Value is HK$39,596 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. JD Health International's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2,956 Mil.
JD Health International's current Enterprise Value is HK$39,596 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. JD Health International's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$58,550 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International Enterprise Value Related Terms
Thank you for viewing the detailed overview of JD Health International's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
JD Health International (HKSE:06618) Business Description
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06618 has been successfully added to your 